CD&R’s unhappy Morrisons experience hasn’t stopped investment bankers from lining up in droves to get a piece of its debt-financing deal for Sanofi’s consumer drug offshoot.
CD&R’s unhappy Morrisons experience hasn’t stopped investment bankers from lining up in droves to get a piece of its debt-financing deal for Sanofi’s consumer drug offshoot.
